Franklin Resources
ODTX icon

Franklin Resources’s Odyssey Therapeutics ODTX Stock Holding History

Franklin Resources’s Portfolio ODTX Stock Details ODTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.36M Hold
275,022
– – ﹤0.01% 1567
2026
Q2 		$5.15M Buy
+275,022
New +$4.82M ﹤0.01% 1586

Other funds holding ODTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Lightspeed Management Company
Lightspeed Management Company Menlo Park, California $2.03B AUM 10.68% 1-Year Est. Return
Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Sands Capital Ventures
Sands Capital Ventures Arlington, Virginia $695M AUM 31.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Franklin Resources's ODTX Position: Q3 2026 in Review

Franklin Resources held its Odyssey Therapeutics (ODTX) position steady in Q3 2026 at 275,022 shares worth $5.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1567.

Franklin Resources first reported a position in ODTX in Q2 2026 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold ODTX as of Q3 2026.

  • Franklin Resources held 275,022 shares of Odyssey Therapeutics worth $5.36M as of Q3 2026.
  • Franklin Resources left its Odyssey Therapeutics share count unchanged in Q3 2026.
  • Odyssey Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q3 2026, its #1567 holding.
  • Franklin Resources first reported a position in Odyssey Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 41 funds tracked by Wall St. Rank held Odyssey Therapeutics as of Q3 2026.

Based on Franklin Resources's 13F filing for Q3 2026, filed 12 Nov 2026.